急性呼吸窘迫综合征（ARDS）患者动脉血氧分压/吸入氧浓度比值（PaO?/FiO?）及柏林评分对越南地区住院预后的预测能力有限 ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

At 1 year after participants’ ICU stay for acute respiratory failure, mean DLCO was about 5% lower in those who had an ICU oxygenation target of 60 vs 90 mm Hg. Cognitive impairment levels among ...

This definitely sounds like the setup to a joke that's only funny to a hyper-specific audience. "What's the difference between a close ratio and a wide ratio transmission? About a second and a half ...

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The pulse-oximetric peripheral oxygen saturation to a fraction of inspired oxygen (SpO 2 /FiO 2) ratio has been suggested as an additional hypoxemia criterion in the new global acute respiratory ...

While talking to other Factorio players or looking up information online you're likely to see people talking about ratios. At a glance, this can seem confusing but we're here to break it down for you ...

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

The models use maximal deflection of esophageal pressure to quantify HFOT-related breathing effort (ΔPes) and the risk for strong breathing effort (ΔPes >10 cmH2O). Two models have been developed to ...

Introduction The use of fibrinolytic therapy has been proposed in severe acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, anticoagulation has received special attention due to ...

ABSTRACT: Background: Recombinant human soluble thrombomodulin (rhTM) was approved for the treatment of disseminated intravascular coagulation in Japan, and rhTM has anti-inflammatory effects.